Sign Up to like & get recommendations! 1
Published in 2019 at "Value in health regional issues"
DOI: 10.1016/j.vhri.2019.01.009
Abstract: BACKGROUND Mucopolysaccharidosis I (MPS-I) is one of the most common types of MPS and lysosomal storage diseases, which impose considerable amount of economic burden on society. OBJECTIVES The aim of this study was to examine… read more here.
Sign Up to like & get recommendations! 1
Published in 2022 at "Journal of Dermatological Treatment"
DOI: 10.1080/09546634.2022.2127304
Abstract: Dupilumab is a monoclonal antibody that inhibits the action of interleukin-4 and interleukin-13. Since FDA approval in 2017, dupilumab has revolutionized the treatment of moderate-tosevere atopic dermatitis (AD) and has gained approval for additional indications.… read more here.
Sign Up to like & get recommendations! 0
Published in 2020 at "Journal of Cardiovascular Electrophysiology"
DOI: 10.1111/jce.14774
Abstract: Catheter ablation is an effective treatment for patients with atrial fibrillation (AF) and heart failure (HF). However, little is known about how healthcare utilization and cost change after ablation in this population. We sought to… read more here.
Sign Up to like & get recommendations! 0
Published in 2025 at "International Journal for Equity in Health"
DOI: 10.1186/s12939-025-02390-w
Abstract: National Reimbursement Drug Price Negotiation (NRDPN) refers to a government-led process of negotiating with pharmaceutical companies to reach reasonable prices for exclusive drugs covered by national reimbursement. Since 2016, the Chinese government has regularly implemented… read more here.
Sign Up to like & get recommendations! 2
Published in 2018 at "Journal of Global Oncology"
DOI: 10.1200/jgo.18.43100
Abstract: Background: Cancer is ranked high among noncommunicable diseases and millions of people in India receive treatment of cancer every year. Aim: The current study aims to evaluate the trends and patte... read more here.
Sign Up to like & get recommendations! 1
Published in 2022 at "PLoS ONE"
DOI: 10.1371/journal.pone.0268495
Abstract: Background Diabetes imposes a large burden on countries’ healthcare expenditures. In Kuwait, diabetes prevalence in adults is estimated at 22.0%%—double the worldwide prevalence (9.3%). There is little current data on pharmaceutical costs in Kuwait of… read more here.
Sign Up to like & get recommendations! 0
Published in 2025 at "Pediatrics"
DOI: 10.1542/peds.2024-068028
Abstract: OBJECTIVE The 2021 American Academy of Pediatrics clinical practice guideline (CPG) for well-appearing febrile infants aims to promote evidence-based care, reduce practice variability, enhance care quality, and optimize cost. We aimed to examine the trends in… read more here.
Sign Up to like & get recommendations! 0
Published in 2021 at "Future oncology"
DOI: 10.2217/fon-2021-1072
Abstract: Background: The introduction of daratumumab into the treatment of multiple myeloma has improved outcomes in patients; however, community oncologists often dose more frequently than the US FDA-approved label. Materials and methods: Integra analyzed its database to… read more here.